These data suggest that the levels of leptin in both serum and lung cancer tissue have a clinical prognostic value for the development and progression of lung cancer; however, it is necessary to continue pursuing studies that will help us to understand the role that exerts leptin in the tumor progression of NSCLC [4]. This evidence concerns the gene LEP and non-small cell lung carcinoma.